ACTIVELLA
LOE ApproachingNDAORALTABLET
Approved
Dec 2006
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
ACTIVELLA by Novo Nordisk is characteristics. Approved for a woman with a uterus for: treatment of moderate to severe vasomotor symptoms due to menopause treatment of moderate to severe symptoms of vulvar, vaginal atrophy due to menopause limitations of use :, vaginal atrophy due to menopause and 1 more indications. First approved in 2006.
Drug data last refreshed 13h ago · AI intelligence enriched 16h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACTIVELLA is an oral combination hormone replacement therapy (HRT) containing estradiol and a progestin, approved for moderate to severe vasomotor symptoms and vulvar/vaginal atrophy in postmenopausal women with an intact uterus. It works by binding to estrogen and progesterone receptors to restore hormone levels, reducing hot flashes and vaginal symptoms while the progestin protects the endometrium. The estradiol component is more potent than other estrogen metabolites at the receptor level.
$0.125MPart D
LOE ApproachingProduct is approaching loss of exclusivity with modest Part D utilization (234 claims in 2023), signaling transition from growth to maintenance-phase team structure.
Mechanism of Action
characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal intracellular human estrogen and is substantially more potent than its metabolites, estrone and estriol, at the receptor level. The primary source of estrogen in…
Indications (4)
Worked on ACTIVELLA at Novo Nordisk? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.